trending Market Intelligence /marketintelligence/en/news-insights/trending/KbL-4UGZlPOcTVw4d-1LEA2 content esgSubNav
In This List

AstraZeneca exec to join Faron Pharmaceuticals as chief commercial officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


AstraZeneca exec to join Faron Pharmaceuticals as chief commercial officer

Faron Pharmaceuticals Oy appointed Juhana Heinonen chief commercial officer, effective January 2018.

Heinonen was previously the global marketing director of AstraZeneca PLC's asthma biologic Fasenra.

At Faron, Heinonen will work on the commercialization strategy for the company's lead candidate, Traumakine, which is in stage phase 3 trials for treating acute respiratory distress syndrome.